Global Intravenous Immunoglobulin (IVIg) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Global Intravenous Immunoglobulin (IVIg) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2015-2026
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2015-2026
2.2 Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 Versus 2026
2.3 Intravenous Immunoglobulin (IVIg) Sales by Region (2015-2026)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2015-2020
2.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2021-2026)
2.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2015-2026)
2.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2015-2020
2.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026)
2.4.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2015-2026)
3 Global Intravenous Immunoglobulin (IVIg) by Manufacturers
3.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2015-2020)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2015-2020)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturer (2015-2020)
3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Intravenous Immunoglobulin (IVIg) Manufacturers Covered: Ranking by Revenue
3.4.2 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Product Type
3.5.1 Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
3.5.3 Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Baxter
4.1.1 Baxter Corporation Information
4.1.2 Baxter Description, Business Overview
4.1.3 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
4.1.4 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Baxter Intravenous Immunoglobulin (IVIg) Revenue by Product
4.1.6 Baxter Intravenous Immunoglobulin (IVIg) Revenue by Application
4.1.7 Baxter Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.1.8 Baxter Intravenous Immunoglobulin (IVIg) Revenue by Sales Channel
4.1.9 Baxter Recent Development
4.2 Grifols
4.2.1 Grifols Corporation Information
4.2.2 Grifols Description, Business Overview
4.2.3 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
4.2.4 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Grifols Intravenous Immunoglobulin (IVIg) Revenue by Product
4.2.6 Grifols Intravenous Immunoglobulin (IVIg) Revenue by Application
4.2.7 Grifols Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.2.8 Grifols Intravenous Immunoglobulin (IVIg) Revenue by Sales Channel
4.2.9 Grifols Recent Development
4.3 CSL
4.3.1 CSL Corporation Information
4.3.2 CSL Description, Business Overview
4.3.3 CSL Intravenous Immunoglobulin (IVIg) Products Offered
4.3.4 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.3.5 CSL Intravenous Immunoglobulin (IVIg) Revenue by Product
4.3.6 CSL Intravenous Immunoglobulin (IVIg) Revenue by Application
4.3.7 CSL Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.3.8 CSL Intravenous Immunoglobulin (IVIg) Revenue by Sales Channel
4.3.9 CSL Recent Development
4.4 Octapharma
4.4.1 Octapharma Corporation Information
4.4.2 Octapharma Description, Business Overview
4.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
4.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Octapharma Intravenous Immunoglobulin (IVIg) Revenue by Product
4.4.6 Octapharma Intravenous Immunoglobulin (IVIg) Revenue by Application
4.4.7 Octapharma Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.4.8 Octapharma Intravenous Immunoglobulin (IVIg) Revenue by Sales Channel
4.4.9 Octapharma Recent Development
4.5 Biotest
4.5.1 Biotest Corporation Information
4.5.2 Biotest Description, Business Overview
4.5.3 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
4.5.4 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Biotest Intravenous Immunoglobulin (IVIg) Revenue by Product
4.5.6 Biotest Intravenous Immunoglobulin (IVIg) Revenue by Application
4.5.7 Biotest Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.5.8 Biotest Intravenous Immunoglobulin (IVIg) Revenue by Sales Channel
4.5.9 Biotest Recent Development
4.6 Kedrion
4.6.1 Kedrion Corporation Information
4.6.2 Kedrion Description, Business Overview
4.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
4.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Kedrion Intravenous Immunoglobulin (IVIg) Revenue by Product
4.6.6 Kedrion Intravenous Immunoglobulin (IVIg) Revenue by Application
4.6.7 Kedrion Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.6.8 Kedrion Recent Development
4.7 Hualan Bio
4.7.1 Hualan Bio Corporation Information
4.7.2 Hualan Bio Description, Business Overview
4.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
4.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue by Product
4.7.6 Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue by Application
4.7.7 Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.7.8 Hualan Bio Recent Development
4.8 CNBG
4.8.1 CNBG Corporation Information
4.8.2 CNBG Description, Business Overview
4.8.3 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
4.8.4 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.8.5 CNBG Intravenous Immunoglobulin (IVIg) Revenue by Product
4.8.6 CNBG Intravenous Immunoglobulin (IVIg) Revenue by Application
4.8.7 CNBG Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.8.8 CNBG Recent Development
4.9 Shanghai RAAS
4.9.1 Shanghai RAAS Corporation Information
4.9.2 Shanghai RAAS Description, Business Overview
4.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
4.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue by Product
4.9.6 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue by Application
4.9.7 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.9.8 Shanghai RAAS Recent Development
4.10 CBPO
4.10.1 CBPO Corporation Information
4.10.2 CBPO Description, Business Overview
4.10.3 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
4.10.4 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.10.5 CBPO Intravenous Immunoglobulin (IVIg) Revenue by Product
4.10.6 CBPO Intravenous Immunoglobulin (IVIg) Revenue by Application
4.10.7 CBPO Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.10.8 CBPO Recent Development
4.11 LFB Group
4.11.1 LFB Group Corporation Information
4.11.2 LFB Group Description, Business Overview
4.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
4.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.11.5 LFB Group Intravenous Immunoglobulin (IVIg) Revenue by Product
4.11.6 LFB Group Intravenous Immunoglobulin (IVIg) Revenue by Application
4.11.7 LFB Group Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.11.8 LFB Group Recent Development
4.12 BPL
4.12.1 BPL Corporation Information
4.12.2 BPL Description, Business Overview
4.12.3 BPL Intravenous Immunoglobulin (IVIg) Products Offered
4.12.4 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.12.5 BPL Intravenous Immunoglobulin (IVIg) Revenue by Product
4.12.6 BPL Intravenous Immunoglobulin (IVIg) Revenue by Application
4.12.7 BPL Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.12.8 BPL Recent Development
4.13 Sichuan Yuanda Shuyang
4.13.1 Sichuan Yuanda Shuyang Corporation Information
4.13.2 Sichuan Yuanda Shuyang Description, Business Overview
4.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
4.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
4.13.5 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue by Product
4.13.6 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue by Application
4.13.7 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue by Geographic Area
4.13.8 Sichuan Yuanda Shuyang Recent Development
5 Breakdown Data by Type
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2026)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2021-2026)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2026)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2015-2026)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2015-2020)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2021-2026)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2015-2026)
5.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2026)
6.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020)
6.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2021-2026)
6.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2026)
6.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2015-2026)
6.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2015-2020)
6.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2021-2026)
6.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2015-2026)
6.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2015-2026
7.2 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
7.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2026)
7.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2026)
7.3 North America Intravenous Immunoglobulin (IVIg) Sales by Type
7.4 North America Intravenous Immunoglobulin (IVIg) Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
8.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2015-2026)
8.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2015-2026)
8.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type
8.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application
9 Europe
9.1 Europe Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2015-2026
9.2 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
9.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2026)
9.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2026)
9.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Type
9.4 Europe Intravenous Immunoglobulin (IVIg) Sales by Application
10 Latin America
10.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2015-2026
10.2 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
10.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2026)
10.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2026)
10.3 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type
10.4 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2026)
11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2026)
11.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type
11.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Intravenous Immunoglobulin (IVIg) Supply Chain Analysis
12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials and Upstream Suppliers
12.3 Intravenous Immunoglobulin (IVIg) Clients Analysis
12.4 Intravenous Immunoglobulin (IVIg) Sales Channel and Sales Model Analysis
12.4.1 Intravenous Immunoglobulin (IVIg) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Intravenous Immunoglobulin (IVIg) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Intravenous Immunoglobulin (IVIg) Distributors
13 Market Dynamics
13.1 Intravenous Immunoglobulin (IVIg) Market Drivers
13.2 Intravenous Immunoglobulin (IVIg) Market Opportunities
13.3 Intravenous Immunoglobulin (IVIg) Market Challenges
13.4 Intravenous Immunoglobulin (IVIg) Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of IVIg Liquid
Table 3. Major Manufacturers of IVIg Powder
Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2020 VS 2026
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2015-2020) & (K Bottle)
Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2021-2026) & (K Bottle)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2015-2020) & (US$ Million)
Table 9. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 10. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2015-2020) & (K Bottle)
Table 11. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturer (2015-2020)
Table 12. Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 13. Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturer (2015-2020)
Table 14. Key Manufacturers Intravenous Immunoglobulin (IVIg) Price (2015-2020) & (USD/Bottle)
Table 15. Ranking of Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue (US$ Million) in 2019
Table 16. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 17. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2019)
Table 18. Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 20. Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Baxter Corporation Information
Table 23. Baxter Description and Business Overview
Table 24. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 25. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 26. Baxter Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 27. Baxter Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 28. Baxter Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 29. Baxter Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Sales Channel
Table 30. Baxter Recent Development
Table 31. Grifols Corporation Information
Table 32. Grifols Description and Business Overview
Table 33. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 34. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 35. Grifols Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 36. Grifols Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 37. Grifols Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 38. Grifols Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Sales Channel
Table 39. Grifols Recent Development
Table 40. CSL Corporation Information
Table 41. CSL Description and Business Overview
Table 42. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 43. CSL Intravenous Immunoglobulin (IVIg) Product
Table 44. CSL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 45. CSL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 46. CSL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 47. CSL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Sales Channel
Table 48. CSL Recent Development
Table 49. Octapharma Corporation Information
Table 50. Octapharma Description and Business Overview
Table 51. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 52. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 53. Octapharma Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 54. Octapharma Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 55. Octapharma Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Octapharma Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Octapharma Recent Development
Table 58. Biotest Corporation Information
Table 59. Biotest Description and Business Overview
Table 60. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 61. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 62. Biotest Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 63. Biotest Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 64. Biotest Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Biotest Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Biotest Recent Development
Table 67. Kedrion Corporation Information
Table 68. Kedrion Description and Business Overview
Table 69. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 70. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 71. Kedrion Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 72. Kedrion Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 73. Kedrion Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Kedrion Recent Development
Table 75. Hualan Bio Corporation Information
Table 76. Hualan Bio Description and Business Overview
Table 77. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 78. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 79. Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 80. Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 81. Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 82. Hualan Bio Recent Development
Table 83. CNBG Corporation Information
Table 84. CNBG Description and Business Overview
Table 85. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 86. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 87. CNBG Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 88. CNBG Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 89. CNBG Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 90. CNBG Recent Development
Table 91. Shanghai RAAS Corporation Information
Table 92. Shanghai RAAS Description and Business Overview
Table 93. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 94. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 95. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 96. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 97. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 98. Shanghai RAAS Recent Development
Table 99. CBPO Corporation Information
Table 100. CBPO Description and Business Overview
Table 101. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 102. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 103. CBPO Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 104. CBPO Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 105. CBPO Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 106. CBPO Recent Development
Table 107. LFB Group Corporation Information
Table 108. LFB Group Description and Business Overview
Table 109. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 110. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 111. LFB Group Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 112. LFB Group Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 113. LFB Group Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 114. LFB Group Recent Development
Table 115. BPL Corporation Information
Table 116. BPL Description and Business Overview
Table 117. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 118. BPL Intravenous Immunoglobulin (IVIg) Product
Table 119. BPL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 120. BPL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 121. BPL Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 122. BPL Recent Development
Table 123. Sichuan Yuanda Shuyang Corporation Information
Table 124. Sichuan Yuanda Shuyang Description and Business Overview
Table 125. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 126. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 127. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Product
Table 128. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Application
Table 129. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) and Market Share by Geographic Area
Table 130. Sichuan Yuanda Shuyang Recent Development
Table 131. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) & (K Bottle)
Table 132. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2021-2026) & (K Bottle)
Table 133. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2015-2020) & (US$ Million)
Table 134. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 135. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) & (K Bottle)
Table 136. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2021-2026) & (K Bottle)
Table 137. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2015-2020) & (US$ Million)
Table 138. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 139. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) & (K Bottle)
Table 140. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 141. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) & (US$ Million)
Table 142. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & (US$ Million)
Table 143. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) & (K Bottle)
Table 144. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) & (K Bottle)
Table 145. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2015-2020) & (K Bottle)
Table 146. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle)
Table 147. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2015-2026) & (US$ Million)
Table 148. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026) & (US$ Million)
Table 149. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) & (K Bottle)
Table 150. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) & (K Bottle)
Table 151. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) & (K Bottle)
Table 152. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 153. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) & (US$ Million)
Table 154. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & (US$ Million)
Table 155. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) & (K Bottle)
Table 156. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) & (K Bottle)
Table 157. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) & (K Bottle)
Table 158. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 159. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) & (US$ Million)
Table 160. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & (US$ Million)
Table 161. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) & (K Bottle)
Table 162. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) & (K Bottle)
Table 163. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) & (K Bottle)
Table 164. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 165. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) & (US$ Million)
Table 166. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & (US$ Million)
Table 167. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) & (K Bottle)
Table 168. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) & (K Bottle)
Table 169. Intravenous Immunoglobulin (IVIg) Key Raw Materials, Industry Status and Trend
Table 170. Intravenous Immunoglobulin (IVIg) Key Raw Materials and Upstream Suppliers
Table 171. Intravenous Immunoglobulin (IVIg) Clients Status and Trend
Table 172. Intravenous Immunoglobulin (IVIg) Typical Clients
Table 173. Intravenous Immunoglobulin (IVIg) Distributors
Table 174. Key Drivers: Impact Analysis (2021-2026)
Table 175. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 176. Intravenous Immunoglobulin (IVIg) Market Opportunities
Table 177. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 178. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 179. Intravenous Immunoglobulin (IVIg) Porter's Five Forces Analysis
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020 & 2026
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020 & 2026
Figure 6. Immunodeficiency Examples
Figure 7. Autoimmune Disease Examples
Figure 8. Acute Infection Examples
Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 11. Global Intravenous Immunoglobulin (IVIg) Market Size 2015-2026 (US$ Million)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Sales 2015-2026 (K Units)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2015-2026)
Figure 15. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2015-2026)
Figure 16. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturer in 2019
Figure 17. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2015-2026)
Figure 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Fore

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs